Exelon faces mounting pressure from market analysts as downward revisions to earnings forecasts and cautious institutional sentiment weigh on the utility stock. Recent developments have created headwinds for the company’s share performance ahead of its upcoming quarterly report.
Earnings Estimates Adjusted
Financial research firm Zacks Research revised its earnings outlook for Exelon downward last Friday. The firm now anticipates full-year 2025 earnings of $2.65 per share, a slight reduction from its previous projection of $2.67. This updated forecast places Zacks just marginally above the consensus estimate of $2.64 per share among market analysts.
Institutional Skepticism Persists
Morgan Stanley maintained its “Equal-Weight” rating on Exelon shares, signaling continued caution toward the utility company. This positioning reflects the investment bank’s restrained outlook for the stock’s near-term performance.
Market activity reflected this tempered sentiment, with Exelon shares declining 1.06 percent to close at $47.60 on Thursday. The downward trend continued through Friday’s trading session, extending the stock’s recent weakness.
Should investors sell immediately? Or is it worth buying Exelon?
Quarterly Performance Provides Mixed Signals
While Exelon surpassed earnings expectations in the second quarter with $0.39 per share—$0.02 above analyst predictions—the company reported revenue of $5.43 billion that fell short of market expectations. Despite this mixed performance, management reaffirmed their full-year guidance range of $2.64 to $2.74 per share.
Looking further ahead, analysts have established quarterly projections for future periods:
* Q4 2025 Forecast: $0.65 EPS
* Q2 2026 Forecast: $0.43 EPS
* Q3 2026 Forecast: $0.75 EPS
Technical Position and Upcoming Catalyst
Exelon shares are currently trading around their 50-day moving average of $44.89, remaining substantially below the 52-week high of $48.51. The stock’s performance suggests investors are awaiting clearer signals about the company’s ability to meet its annual targets.
All eyes now turn to November 4th, when Exelon will report third-quarter 2025 results. This announcement represents a critical test for the company to demonstrate its capacity to counter the recent downward revisions to earnings projections and restore investor confidence.
Ad
Exelon Stock: Buy or Sell?! New Exelon Analysis from February 2 delivers the answer:
The latest Exelon figures speak for themselves: Urgent action needed for Exelon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 2.
Exelon: Buy or sell? Read more here...
